Corporate

Illumina @ a glance

A snapshot of the company, its markets, sequencers and more

Recent Articles

It’s all about accessibility: Developing technical training for the MiSeq i100
It’s all about accessibility: Developing technical training for the MiSeq i100
The rare disease community fights for precision medicine, from diagnosis to cure
The rare disease community fights for precision medicine, from diagnosis to cure
Admera Health uses the NovaSeq X Plus to expand capabilities
Admera Health uses the NovaSeq X Plus to expand capabilities